David Watson - 10 Feb 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
/s/ David Watson
Issuer symbol
APLS
Transactions as of
10 Feb 2022
Transactions value $
-$23,136
Form type
4
Filing time
14 Feb 2022, 17:36:02 UTC
Previous filing
01 Feb 2022
Next filing
27 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$23,135 -491 -0.37% $47.12 132,444 10 Feb 2022 Direct F1
holding APLS Common Stock 3,333 10 Feb 2022 Custodial Account for Son F2
holding APLS Common Stock 6,667 10 Feb 2022 The Watson Education Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.
F2 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F3 The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.